Home
Site Search
Use small fonts Use medium fonts Use large fonts Email link to page PDF this page

Partners

Related people 1
Alison Hayman Alison Hayman
t: 416 815 4240
Email Alison Hayman email
Bernice Karn Bernice Karn
t: 416 869 5721
Email Bernice Karn email
Sean Maniaci Sean Maniaci
t: 416 860 6466
Email Sean Maniaci email
Cathy L. Mercer Cathy L. Mercer
t: 416 869 5772
Email Cathy L. Mercer email
Charles (Chuck) Rich Charles (Chuck) Rich
t: 416 869 5953
Email Charles (Chuck) Rich email
Frank Robinson Frank Robinson
t: 416 869 5991
Email Frank Robinson email

Associates

Related people 2
James Lyle James Lyle
t: 416 869 5376
Email James Lyle email
Amanda Metallo Amanda Metallo
t: 416 869 5446
Email Amanda Metallo email
A. Chandimal Nicholas A. Chandimal Nicholas
t: 416 860 6750
Email A. Chandimal Nicholas email
Chad Podolsky Chad Podolsky
t: 416 869 5456
Email Chad Podolsky email
Stefanie Sebanc Stefanie Sebanc
t: 416 869 5405
Email Stefanie Sebanc email
Jonathan Sherman Jonathan Sherman
t: 416 869 5409
Email Jonathan Sherman email
Michael Weizel Michael Weizel
t: 416 860 6880
Email Michael Weizel email

Canadian Cannabis & Life Science Blog Graphic

Cannabis

Cassels Brock has distinguished itself at the forefront of the cannabis industry, providing a wide range of expertise in connection with general corporate, intellectual property, securities, regulatory, branding, celebrity endorsements and other related matters.

We act as corporate and securities counsel for various private and public companies in the cannabis industry, as well as licensed producers and late stage applicants on various matters including licensing, financings, M&A and go-public transactions.

We have also worked with many ancillary players in the cannabis space including private equity, device, branding, research and pharmacology companies. We have also acted in the capacity of underwriters’ counsel on numerous equity and debt financings and public offerings completed for cannabis companies.

Cassels Brock is respected for our contribution to thought leadership in connection with financing, structuring and regulatory issues in the cannabis industry, and are frequently called upon to write and speak on advancements and innovation in the industry and to work with prominent business and political leaders on groundbreaking issues.